본문으로 건너뛰기
공식 EU 표시명용어집 항목 28210

TAFLUPROST

이 기록은 EU 화장품 표시에 사용하는 공식 일반 원료 명칭을 확인해 줍니다. 그것만으로는 해당 물질이 허용되거나 제한이 없거나 안전하다는 것이 확인되지 않습니다.

글로벌 근거 요약

확인된 정체는 색인된 시장 데이터세트 13개 중 1개에서 일치하는 규제 근거가 있습니다: 국가 기록 1건과 EU 부속서 기록 0건. 모든 결과와 근거 부족 사항은 아래에 나열되어 있습니다.

근거가 있는 시장 1곳
확인한 시장
13
근거가 있는 시장
1
근거 부족
12
확인된 식별자
15

확인된 물질 정체

CAS:209860-87-7745-65-3155206-00-140665-92-7363-24-635121-78-940666-16-8130209-82-459122-46-2157283-68-681846-19-7120373-36-6130209-76-61005193-64-5157283-66-4
원료 색인 기록:
TAFLUPROST
화장품 기능: HAIR CONDITIONING

Isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-((1E)-3,3-difluoro-4-phenoxybut-1- enyl)-3,5-dihydroxycyclopentyl}hept-5-enoate

일치 또는 보고된 명칭 3개
TAFLUPROSTtafluprostProstaglandins, their salts and derivatives and their analogs

13개 시장 전체의 규제 근거

일치하는 각 기록을 열어 범위, 농도, 조건, 경고 문구 및 공식 출처 버전을 확인하세요.

데이터세트 범위와 다음 조치를 보려면 가로로 스와이프하거나 스크롤하세요.

시장결과기록데이터세트의미 / 다음 조치
European Union
EU
일치하는 항목 없음0
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review.
Great Britain
GB
일치하는 항목 없음0
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.
Canada
CA
Prohibited1기록 열기 1
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
연결된 모든 기록과 정확한 조건을 검토하세요.
New Zealand
NZ
일치하는 항목 없음0
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
The searchable spreadsheet is an aid; the legal Group Standard and incorporated notices remain authoritative.
ASEAN
ASEAN
일치하는 항목 없음0
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
Regional annex coverage does not replace member-state implementation dates, notifications or national deviations.
China
CN
일치하는 항목 없음0
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.
Japan
JP
일치하는 항목 없음0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
일치하는 항목 없음0
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
Korean source wording is canonical and other positive lists/notices may still apply to the formulation.
United States
US
일치하는 항목 없음0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
일치하는 항목 없음0
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Brazil
BR
일치하는 항목 없음0
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.
India
IN
일치하는 항목 없음0
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
The standards are separate controlled publications; absence from a locally indexed excerpt is not permission.
Saudi Arabia
SA
일치하는 항목 없음0
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.
이 필터와 일치하는 시장 행이 없습니다.

일치하는 시장 기록 및 조건

화학적 정체 및 특성

CAS 1005193-64-5의 PubChem 2D 화학 구조
CAS 1005193-64-5PubChem CID 50940350

TrifluoroMethyl Dechloro

IUPAC 명칭
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
분자식
C25H34F3NO5
분자량
485.5 g/mol
정확한 질량
485.23890767 Da
XLogP3
3.0
위상 극성 표면적
99.0 Ų
수소 결합 공여체
4
수소 결합 수용체
8
공유결합 단위
1
정의된 입체중심
5

다른 이름

N-Ethyl Fluprostenol Carboxamide(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-N-ethyl-5-heptenamideTrifluoroMethylDechloroC25H34F3NO5Trifluoromethyl Dechloro Ethylcloprostenolamide(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)-N-ethylhept-5-enamide(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]-N-ethyl-hept-5-enamide

추가 과학 데이터베이스의 근거

NIH PubChem PUG-View
식별자 정확히 일치50940350

Attributed physical-property, hazard, environmental and use annotations.

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
EMBL-EBI ChEBI정확히 일치하는 기록 없음2026-08-31
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-09-02에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 120373-36-6의 PubChem 2D 화학 구조
CAS 120373-36-6PubChem CID 5311236

Unoprostone

Unoprostone is a ketone, an oxo monocarboxylic acid and a prostaglandins Falpha. It has a role as an antihypertensive agent and an antiglaucoma drug. — ChEBI

IUPAC 명칭
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl]hept-5-enoic acid
분자식
C22H38O5
분자량
382.5 g/mol
정확한 질량
382.27192431 Da
XLogP3
3.7
위상 극성 표면적
94.8 Ų
수소 결합 공여체
3
수소 결합 수용체
5
공유결합 단위
1
정의된 입체중심
4

다른 이름

unoprostona13,14-dihydro-15-keto-20-ethyl PGF2alpha6X4F561V3W(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl]hept-5-enoic acidCHEBI:39455(+)-(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl)-5-heptenoic acid9,11-dihydroxy-15-oxo-20a,20b-dihomoprost-5Z-en-1-oic acid(5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl)hept-5-enoic acid
보고된 명칭 16개 더 보기
unoprostonumRefChem:1100656S01EE02Unoprostone [MI]Unoprostone [INN]UnoprostaneUnoprostone (INN)13,14-Dihydro-15-keto-20-ethyl prostaglandin f2alphaUNII-6X4F561V3WUNOPROSTONE [VANDF]UNOPROSTONE [WHO-DD]HMS3648D22EBC-26874DA-68484HY-106916CS-0026907
외부 데이터베이스 식별자

추가 과학 데이터베이스의 근거

NIH PubChem PUG-View
식별자 정확히 일치5311236

Attributed physical-property, hazard, environmental and use annotations.

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 130209-76-6의 PubChem 2D 화학 구조
CAS 130209-76-6PubChem CID 5283107

17-phenyl-trinor-PGF2alpha isopropyl ester

17-phenyl-trinor-PGF2alpha isopropyl ester is a prostanoid. — ChEBI

IUPAC 명칭
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoate
분자식
C26H38O5
분자량
430.6 g/mol
정확한 질량
430.27192431 Da
XLogP3
3.8
위상 극성 표면적
87.0 Ų
수소 결합 공여체
3
수소 결합 수용체
5
공유결합 단위
1
정의된 입체중심
5

다른 이름

isopropyl 9S,11R,15S-trihydroxy-17-phenyl-18,19,20-trinor-5Z,13E-prostadienoateRefChem:1057638Bimatoprost isopropyl ester17-Phenyl trinor Pgf2alpha-IprdehydrolatanoprostPhDH 100A1IFH52MD8T17-Phenyl trinor PGF2|A isopropyl ester
보고된 명칭 16개 더 보기
17-Phenyl-18,19,20-trinor-pgf2alpha-1-isopropyl ester17-phenyl trinor PGF2alpha isopropyl esterisopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)hept-5-enoatePhdh100A5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-, 1-methylethyl ester, (5Z)-UNII-1IFH52MD8TBimatoprost Acid Isopropyl Ester5-HEPTENOIC ACID, 7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3S)-3-HYDROXY-5-PHENYL-1-PENTEN-1-YL)CYCLOPENTYL)-, 1-METHYLETHYL ESTER, (5Z)-PGF2Alpha,17-phenylCHEBI:137717JGZRPRSJSQLFBO-FWPUOYPASA-NHMS3648J1817-Phenyl-18,19,20-trinor-prostaglandin F2alpha-1-isopropyl esterFA 26:7;O3HY-116161A(1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-1-Methylethyl 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-5-heptenoate
외부 데이터베이스 식별자

추가 과학 데이터베이스의 근거

NIH PubChem PUG-View
식별자 정확히 일치5283107

Attributed physical-property, hazard, environmental and use annotations.

  • Signal: Danger 출처: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302+H312+H332 (100%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]; H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal]; H332 (100%): Harmful if inhaled [Warning Acute toxicity, inhalation]; H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity] 출처: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P318, P321, P330, P362+P364, P405, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. 출처: European Chemicals Agency (ECHA)

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-09-02에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 130209-82-4의 PubChem 2D 화학 구조
CAS 130209-82-4PubChem CID 5311221

Latanoprost

Latanoprost is a prostaglandin Falpha that is the isopropyl ester prodrug of latanoprost free acid. Used in the treatment of open-angle glaucoma and ocular hypertension. It has a role as an EC 4.2.1.1 (carbonic anhydrase) inhibitor, an antihypertensive agent, an antiglaucoma drug and a prodrug. It is a triol, an isopropyl ester and a prostaglandins Falpha. It is functionally related to a latanoprost free acid. — ChEBI

IUPAC 명칭
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate
분자식
C26H40O5
분자량
432.6 g/mol
정확한 질량
432.28757437 Da
XLogP3
4.3
위상 극성 표면적
87.0 Ų
수소 결합 공여체
3
수소 결합 수용체
5
공유결합 단위
1
정의된 입체중심
5

다른 이름

XalatanPhXA41PHXA-41XA41PhXA 41XA-41IYUZEHlatanoprost (isopropyl ester)
보고된 명칭 16개 더 보기
latanoprostum6Z5B6HVF6OXELPROSIsopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoateT-2345CHEBI:6384propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoateT2345XALACOM COMPONENT LATANOPROSTpropan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoateLatanoprost PF5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)-, 1-methylethyl ester, (1R-(1-alpha(Z),2-beta(R*),3-alpha,5-alpha))-Monopostisopropyl (z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(3r)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoatepropan-2-yl (5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoatepropan-2-yl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate
외부 데이터베이스 식별자

추가 과학 데이터베이스의 근거

NIH PubChem PUG-View
식별자 정확히 일치5311221

Attributed physical-property, hazard, environmental and use annotations.

  • Note: This chemical does not meet GHS hazard criteria for 0.7% (1 of 145) of reports. 출처: European Chemicals Agency (ECHA)
  • Signal: Danger 출처: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H300 (63.4%): Fatal if swallowed [Danger Acute toxicity, oral]; H301 (11%): Toxic if swallowed [Danger Acute toxicity, oral]; H361 (62.1%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] 출처: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P264, P270, P280, P301+P316, P318, P321, P330, P405, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 145 reports by companies from 16 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 145 reports by companies.; There are 15 notifications provided by 144 of 145 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
  • Toxicity Summary: Researchers found no carcinogenesis or mutagenesis with latanoprost, and the drug did not affect fertility in animal studies. However, latanoprost was noted to cause a chromosomal aberration in treated human lymphocytes. Intravenous infusion of 3 μg/kg of latanoprost in healthy volunteers produced plasma concentrations 200 times higher than during clinical treatment with latanoprost ophthalmic solution, and researchers identified no ADR. There is no evidence to establish a correlation between latanoprost administration and ocular or cutaneous melanoma.; Intravenous infusion of 5.5 to 10 μg/kg resulted in fatigue, sweating, dizziness, nausea, and abdominal pain. According to the manufacturer's labeling, treatment should be symptomatic if there is an overdosage with latanoprost ophthalmic solution. 출처: StatPearls
  • Uses: Use (kg) in USA (2002): 1; Consumption (g per capita) in the USA (2002): 3.3e-06; Calculated removal (%): 100 출처: NORMAN Suspect List Exchange

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 155206-00-1의 PubChem 2D 화학 구조
CAS 155206-00-1PubChem CID 5311027

Bimatoprost

Bimatoprost is a monocarboxylic acid amide. It has a role as an antihypertensive agent and an antiglaucoma drug. — ChEBI

IUPAC 명칭
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
분자식
C25H37NO4
분자량
415.6 g/mol
정확한 질량
415.27225866 Da
XLogP3
2.8
위상 극성 표면적
89.8 Ų
수소 결합 공여체
4
수소 결합 수용체
4
공유결합 단위
1
정의된 입체중심
5

다른 이름

LumiganLatisseAGN 192024ProstamideAGN-192024bimatoprostumDURYSTA(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide
보고된 명칭 16개 더 보기
CHEBI:51230GANFORT COMPONENT BIMATOPROST5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylhept-5-enamide(5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide(5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)-N-ethylhept-5-enamide(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((E,3S)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)-N-ethylhept-5-enamide(Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-5-heptenamide192024, AGNRefChem:54542S01EE035-Heptenamide, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-,(5Z)-(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)-N-ethylhept-5-enamide(E)-7-[3,5-dihydroxy-2-[(E)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide5-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-, (5Z)-UNII-QXS94885MZ
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-09-02에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 157283-66-4의 PubChem 2D 화학 구조
CAS 157283-66-4PubChem CID 59938277

Isopropyl Cloprostenate

IUPAC 명칭
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate
분자식
C25H35ClO6
분자량
467.0 g/mol
정확한 질량
466.2122165 Da
XLogP3
3.8
위상 극성 표면적
96.2 Ų
수소 결합 공여체
3
수소 결합 수용체
6
공유결합 단위
1
정의된 입체중심
5

다른 이름

Cloprostenol isopropyl esterIsopropyl cloprostenolUNII-765298537GCPG-6112955-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl)-3,5-dihydroxycyclopentyl)-, 1-methylethyl ester, (5Z)-5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, 1-methylethyl ester, (5Z)-CPG-6112-955-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, 1-methylethyl ester, (1R-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-
보고된 명칭 16개 더 보기
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5Z)-RefChem:149814ISOPROPYL CLOPROSTENATE [INCI]5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5Z)-(9CI)682-025-2(+)-Cloprostenol isopropyl esterisopropyl (Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate(+)-16-m-chlorophenoxy tetranor Prostaglandin F2alpha isopropyl esterISOPROPYL CLOPROSTENATC25H35ClO6D-cloprostenol isopropyl ester(+)-CloprostenolisopropylesterMSK2978CPG 6112-95HY-100571CS-0019712

체크섬이 유효한 CAS 일치를 통해 2026-09-02에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 157283-68-6의 PubChem 2D 화학 구조
CAS 157283-68-6PubChem CID 5282226

Travoprost

Travoprost is the isopropyl ester of prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of travoprost are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. It is a pro-drug; the isopropyl ester group is hydrolysed by esterases in the cornea to the biologically active free acid, fluprostenol. It has a role as an antihypertensive agent, an antiglaucoma drug, a prodrug, a prostaglandin receptor agonist and an ophthalmology drug. It is an isopropyl ester, a prostaglandins Falpha and a member of (trifluoromethyl)benzenes. It is functionally related to a fluprostenol. — ChEBI

IUPAC 명칭
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
분자식
C26H35F3O6
분자량
500.5 g/mol
정확한 질량
500.23857332 Da
XLogP3
4.1
위상 극성 표면적
96.2 Ų
수소 결합 공여체
3
수소 결합 수용체
9
공유결합 단위
1
정의된 입체중심
5

다른 이름

TravatanTravatan ZIzbaAL-6221AL6221Otx-tptravoprostumIDOSE TR
보고된 명칭 16개 더 보기
WJ68R08KX9CHEBI:746859NSC-760366DUOTRAV COMPONENT TRAVOPROSTpropan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl]cyclopentyl]hept-5-enoate5-Heptenoic acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl ester, (5Z)-isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoatepropan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoateZ, TravatanAL 6221ISOPROPYL (Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3R)-3-HYDROXY-4-((alpha,alpha,alpha-TRIFLUORO-M-TOLYL)OXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOATEpropan-2-yl (5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoateTravoprost OphthalmicTravoprost IntracameralRefChem:56256Travoprost (Isomer Free)
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 209860-87-7의 PubChem 2D 화학 구조
CAS 209860-87-7PubChem CID 9868491

Tafluprost

Tafluprost is a prostaglandin Falpha that is prostaglandin F2alpha in which the carboxylic acid function has been converted to the corresponding isopropyl ester and the 3-hydroxy-1-octenyl side-chain is substituted by 3,3-difluoro-4-phenoxybut-1-enyl. Used for treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It has a role as a prostaglandin receptor agonist. It is an isopropyl ester, a prostaglandins Falpha and an organofluorine compound. It is functionally related to a prostaglandin F2alpha. — ChEBI

IUPAC 명칭
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate
분자식
C25H34F2O5
분자량
452.5 g/mol
정확한 질량
452.23743050 Da
XLogP3
4.5
위상 극성 표면적
76.0 Ų
수소 결합 공여체
2
수소 결합 수용체
7
공유결합 단위
1
정의된 입체중심
4

다른 이름

AFP-168TaflotanZioptanSaflutanMK-24521O6WQ6T7G3CHEBI:66899MK2452
보고된 명칭 16개 더 보기
propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl]hept-5-enoatetafluprostumtafluprost opthalmic5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5Z)-ISOPROPYL (5Z)-7-((1R,2R,3R,5S)-2-((1E)-3,3-DIFLUORO-4-PHENOXYBUT-1-ENYL)-3,5-DIHYDROXYCYCLOPENTYL)HEPT-5-ENOATEIsopropyl (5Z)-7-{(1R,2R,3R,5S)-2-((1E)-3,3-difluoro-4-phenoxybut-1-enyl)-3,5-dihydroxycyclopentyl}hept-5-enoatepropan-2-yl (5Z)-7-((1R,2R,3R,5S)-2-((1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoatepropan-2-yl (Z)-7-((1R,2R,3R,5S)-2-((E)-3,3-difluoro-4-(phenoxy)but-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoatepropan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-(phenoxy)but-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoateTafluprost OphthalmicRefChem:57842S01EE055-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl)-3,5-dihydroxycyclopentyl)-, 1-methylethyl ester, (5Z)-1-methylethyl (5Z)-7-((1R,2R, 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate(Z)-isopropyl 7-((1R,2R,3R,5S)-2-((E)-3,3-difluoro-4-phenoxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoateC25H34F2O5
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-09-02에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 35121-78-9의 PubChem 2D 화학 구조
CAS 35121-78-9PubChem CID 5282411

Prostacyclin

Prostaglandin I2 is a prostaglandins I. It has a role as a mouse metabolite. It is a conjugate acid of a prostaglandin I2(1-). — ChEBI

IUPAC 명칭
(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
분자식
C20H32O5
분자량
352.5 g/mol
정확한 질량
352.22497412 Da
XLogP3
2.9
위상 극성 표면적
87.0 Ų
수소 결합 공여체
3
수소 결합 수용체
5
공유결합 단위
1
정의된 입체중심
5

다른 이름

epoprostenolprostaglandin I2PGI2VasocyclinProstaglandin XEpoprostenolumACT-385781ADCR9Z582X0
보고된 명칭 16개 더 보기
U-53217(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acidU-53,217CHEBI:155526,9S-epoxy-11R,15S-dihydoxy-5Z,13E-prostadienoic acidEpoprostanol(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoateProsta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9alpha,11alpha,13E,15S)-Prostaglandin I(2)epoprostenolo(5Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((E,3S)-3-hydroxyoct-1-enyl)-3,3a,4,5,6,6a-hexahydrocyclopenta(b)furan-2-ylidene)pentanoic acid(5Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((E,3S)-3-hydroxyoct-1-enyl)-3,3a,4,5,6,6a-hexahydrocyclopenta(d)furan-2-ylidene)pentanoic acid(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[d]furan-2-ylidene]pentanoic acidRefChem:57239B01AC09Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 363-24-6의 PubChem 2D 화학 구조
CAS 363-24-6PubChem CID 5280360

Prostaglandin E2

Prostaglandin E2 is prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins. It has a role as an oxytocic, a mouse metabolite and a human metabolite. It is a conjugate acid of a prostaglandin E2(1-). — ChEBI

IUPAC 명칭
(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
분자식
C20H32O5
분자량
352.5 g/mol
정확한 질량
352.22497412 Da
XLogP3
2.8
위상 극성 표면적
94.8 Ų
수소 결합 공여체
3
수소 결합 수용체
5
공유결합 단위
1
정의된 입체중심
4

다른 이름

DinoprostonePGE2Prostin E2PrepidilCervidilMinprostin E2PropessMinprositin E2
보고된 명칭 16개 더 보기
DinoprostonDinoprostonumCerviprostDinoprostonaEnzaprost ECerviprimeProstenonePGE2alphaU-12062(5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acidProstaglandin E2alpha(E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acidU 12062K7Q1JQR04MProstaglandin E(2)(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 40665-92-7의 PubChem 2D 화학 구조
CAS 40665-92-7PubChem CID 5311053

Cloprostenol

Cloprostenol is a prostanoid. — ChEBI

IUPAC 명칭
(Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid
분자식
C22H29ClO6
분자량
424.9 g/mol
정확한 질량
424.1652663 Da
XLogP3
2.7
위상 극성 표면적
107.0 Ų
수소 결합 공여체
4
수소 결합 수용체
6
공유결합 단위
1
정의된 입체중심
5

다른 이름

CloprostenolumOestrophaneEstrofanEstrophanEstrophaneOestrophan5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-rel-(5Z)-7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid
보고된 명칭 16개 더 보기
(5Z)-7-{(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-Chlorophenoxy)-3-hydroxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoic acid(Z)-7-((1R,2R,3R,5S)-2-((E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoic acidSodium, CloprostenolRefChem:56481Cloprostenol Monosodium SaltMonosodium Salt, CloprostenolSalt, Cloprostenol MonosodiumICI80,966ICI 80,966(Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(3-Chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptensaeure255-028-8(+)-CloprostenolDalmazinR-CloprostenolDalmaprost DD-Cloprostenol
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 40666-16-8의 PubChem 2D 화학 구조
CAS 40666-16-8PubChem CID 5311100

Fluprostenol

Fluprostenol is an organofluorine compound that is racemic prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of its isopropyl ester prodrug, travoprost, are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. The isopropyl ester group of travoprost is hydrolysed to the biologically active free acid by esterases in the cornea. It has a role as an antihypertensive agent, an antiglaucoma drug, a female contraceptive drug, an abortifacient and a prostaglandin receptor agonist. It is a hydroxy monocarboxylic acid, a prostaglandins Falpha and a member of (trifluoromethyl)benzenes. — ChEBI

IUPAC 명칭
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoic acid
분자식
C23H29F3O6
분자량
458.5 g/mol
정확한 질량
458.19162313 Da
XLogP3
2.9
위상 극성 표면적
107.0 Ų
수소 결합 공여체
4
수소 결합 수용체
9
공유결합 단위
1
정의된 입체중심
5

다른 이름

Fluprostenolumtravoprost free acidFluoprostenolICI 81,008358S7VUE5NCHEBI:60782ICI-80008 FREE ACIDICI 80,008 FREE ACID
보고된 명칭 16개 더 보기
ICI 81008ICI-81008rac-(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoic acid(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-enyl)cyclopentyl)hept-5-enoic acidrac-(5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoic acidRefChem:921725255-029-3(+)-fluprostenoltravoprost acidFluprostenol, (+)-EINECS 255-029-3(+/-)-FluprostenolMEH3MCE8X1AL-58485-Heptenoic acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-buten-1-yl)cyclopentyl)-, (5Z)-C23H29F3O6
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 59122-46-2의 PubChem 2D 화학 구조
CAS 59122-46-2PubChem CID 5282381

Misoprostol

7-[(1R,2R,3R)-3-hydroxy-2-(4-hydroxy-4-methyloct-1-enyl)-5-oxocyclopentyl]heptanoic acid methyl ester is a prostanoid. — ChEBI

IUPAC 명칭
methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate
분자식
C22H38O5
분자량
382.5 g/mol
정확한 질량
382.27192431 Da
XLogP3
3.7
위상 극성 표면적
83.8 Ų
수소 결합 공여체
2
수소 결합 수용체
5
공유결합 단위
1
정의된 입체중심
3

다른 이름

CytotecMisoprostolumSC-29333SC 293330E43V0BB57ARTHROTEC COMPONENT MISOPROSTOLmethyl (11alpha,13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oatemethyl 7-[(1R,2R,3R)-3-hydroxy-2-[(1E)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate
보고된 명칭 16개 더 보기
Apo MisoprostolProst-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)-misoprostoloMysodelleTopogyneNovo MisoprostolMisoprostol 1%methyl 7-((1R,2R,3R)-3-hydroxy-2-((1E)-4-hydroxy-4-methyloct-1-en-1-yl)-5-oxocyclopentyl)heptanoateRefChem:55654Misoprostol 1% DispersionCHEBI:63610A02BB01G02AD06SC 30249664-288-5Isprelor
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 745-65-3의 PubChem 2D 화학 구조
CAS 745-65-3PubChem CID 5280723

Alprostadil

Prostaglandin E1 is a prostaglandins E. It has a role as a vasodilator agent, an anticoagulant, a platelet aggregation inhibitor and a human metabolite. It is a conjugate acid of a prostaglandin E1(1-). — ChEBI

IUPAC 명칭
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
분자식
C20H34O5
분자량
354.5 g/mol
정확한 질량
354.24062418 Da
XLogP3
3.2
위상 극성 표면적
94.8 Ų
수소 결합 공여체
3
수소 결합 수용체
5
공유결합 단위
1
정의된 입체중심
4

다른 이름

Prostaglandin E1PGE1CaverjectEdexMuseAlprostadilumBefarProstin VR Pediatric
보고된 명칭 16개 더 보기
VitarosPrinkPGE-1Prostavasin(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acidCaverject ImpulsePGE1alphaLipo PGE1Prostaglandin E1alpha11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoateU-101369-oxo-11R,15S-dihydroxy-13E-prostaenoic acidF5TD010360U-10,136CHEBI:15544
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 81846-19-7의 PubChem 2D 화학 구조
CAS 81846-19-7PubChem CID 6918140

Treprostinil

Treprostinil is a carboxylic acid and a carbotricyclic compound. It has a role as a cardiovascular drug, a vasodilator agent, an antihypertensive agent, a platelet aggregation inhibitor, a vitamin K antagonist and a human blood serum metabolite. — ChEBI

IUPAC 명칭
2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
분자식
C23H34O5
분자량
390.5 g/mol
정확한 질량
390.24062418 Da
XLogP3
4.5
위상 극성 표면적
87.0 Ų
수소 결합 공여체
3
수소 결합 수용체
5
공유결합 단위
1
정의된 입체중심
5

다른 이름

UniprostRumodolinTyvasoUT-15LRX-15treprostinilo15AU81treprostinilum
보고된 명칭 16개 더 보기
Tyvaso dpiRUM6K67ESG15-AU-81CHEBI:50861L-606((1R,2R,3aS,9aS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cylopent(b)naphthalen-5-yl)oxy)acetate2-{[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H,2H,3H,3aH,4H,9H,9aH-cyclopenta[b]naphthalen-5-yl]oxy}acetic acid({(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl}oxy)acetic acidAcetic acid, ((2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-(3-hydroxyoctyl)-1H-benz(f)inden-5-yl)oxy)-, (1R-(1alpha(S*),2beta,3aalpha,9aalpha))-trepostinil sodium(((1R,2R,3aS,9aS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta(b)naphthalen-5-yl)oxy)acetic acid[(1R,2R,3aS,9aS)-2-Hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cylopent[b]naphthalen-5-yl]oxy]acetate2-(((1R,2R,3aS,9aS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-1H,2H,3H,3aH,4H,9H,9aH-cyclopenta(b)naphthalen-5-yl)oxy)acetic acid2-(((2R,3R,3aS,9aS)-2-hydroxy-3-((3S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta(g)naphthalen-8-yl)oxy)acetic acid2-[[(2R,3R,3aS,9aS)-2-hydroxy-3-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-8-yl]oxy]acetic acidRefChem:56257
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

추가 공신력 있는 물질 조사

각 링크는 해당 출처에서 이 정체를 검색합니다. 링크는 조사 경로일 뿐이며, 그 출처에 정확히 일치하는 기록이 있다는 주장이 아닙니다. 각 출처의 성격과 법적 비중

이 기록 활용하기

처방에서 선별독립 비교 열기

공식 출처 및 범위

집행위원회 시행결정 (EU) 2025/1175(데이터세트 버전 EU 2025/1175)에서 가져왔습니다. 이 용어집은 제19조 제1항 (g)호에서 요구하는 성분 목록에 사용할 일반 원료 명칭을 제공하며, 승인 또는 안전성 목록이 아닙니다.

공식 결정 열기